drugset / Trial / NCT05755932

Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in Healthy Participants

NCT05755932 ↗

Phase 3 Completed 35 enrolled AstraZeneca
RandomizedCrossoverQuadruple-blindBasic science

Summary

A Study to Assess the Effect of the HFO MDI Propellant on Mucociliary Clearance Compared to the HFA MDI Propellant in Healthy Participants

Timeline

Start
2023-06-14
Primary completion
2024-07-22
Completion
2024-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject HFO-1234ze Unknown 6 unknown Inhaled
Comparator NORFLURANE Other / unclassified 6 unknown Inhaled